Beyond Air (NASDAQ:XAIR) Issues Earnings Results, Beats Expectations By $0.02 EPS

by · The Cerbat Gem

Beyond Air (NASDAQ:XAIR – Get Free Report) posted its earnings results on Monday. The company reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.02, Zacks reports. Beyond Air had a negative net margin of 2,369.17% and a negative return on equity of 243.52%. The business had revenue of $0.80 million for the quarter, compared to analyst estimates of $1.19 million. During the same quarter in the previous year, the business posted ($0.51) EPS.

Beyond Air Stock Down 2.3 %

Shares of Beyond Air stock traded down $0.01 during trading on Wednesday, hitting $0.48. 233,429 shares of the stock traded hands, compared to its average volume of 548,346. Beyond Air has a twelve month low of $0.30 and a twelve month high of $2.36. The company has a quick ratio of 2.42, a current ratio of 2.63 and a debt-to-equity ratio of 0.84. The company has a fifty day moving average price of $0.40 and a two-hundred day moving average price of $0.68.

Insiders Place Their Bets

In other news, CEO Steven A. Lisi bought 1,476,626 shares of the company’s stock in a transaction on Thursday, September 26th. The stock was purchased at an average cost of $0.50 per share, for a total transaction of $738,313.00. Following the completion of the transaction, the chief executive officer now owns 3,249,411 shares of the company’s stock, valued at $1,624,705.50. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 20.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on XAIR shares. Piper Sandler cut their price target on shares of Beyond Air from $3.50 to $1.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Roth Capital upgraded Beyond Air to a “strong-buy” rating in a research note on Friday, August 16th. Finally, Roth Mkm restated a “buy” rating and set a $2.00 price objective on shares of Beyond Air in a research report on Friday, August 16th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Beyond Air currently has an average rating of “Buy” and an average price target of $3.67.

View Our Latest Analysis on Beyond Air

Beyond Air Company Profile

(Get Free Report)

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.

Recommended Stories